EDC Selected Again (And Again) To Support Biotech Advances In Diabetes

About one in 10 people in the United States have some form of diabetes —with over 20 percent of them undiagnosed. Although challenging, studying diabetes is important because of its widespread impact on the body. If left uncontrolled, diabetes can cause major complications, such as stroke, amputation, blindness, and death.

In a recent discussion, one eClinical technologies and services provider sat down with a leading biotechnology company to find out how their EDC platform has helped to advance diabetes diagnostics and therapies. Additionally, the company’s Director of Clinical Data Management shed light on why its team has selected this provider again and again.